Abstract
Cervical cancer stands out due to the high mortality rate worldwide. Despite the available treatments, cervical cancer is still considered a public health problem and new therapeutic approaches are needed. The objective of this project is to evaluate a treatment composed of immunotherapy based on bone marrow differentiated dendritic cells (BMDCs) activated in vitro by the recombinant prot…